Overall, the frequency of CRLF2 rearrangements in B-ALL is approximately 5% and the rate gets higher in cases without canonical B-ALL alterations (10–30%) and in patients with Down syndrome (> 50%) [16, 27, 28, 31, 32]. This evidence concerns the gene CRLF2 and precursor B-cell acute lymphoblastic leukemia.